Skip to main content
. 2019 Nov;17(11):1004–1020. doi: 10.2174/1570159X17666181227164947

Table 2. PON1 activity in major depressive disorder (MDD).

Subjects N Genotyped for PON1? PON1 Activity Substrate Exclusion Criteria Statistical Adjustment of the Data Results Refs.
Adults drug-free for at least 3 weeks CON: 36
Cases: 86
Q192R PO
PA
Comorbid axis I or II DSM-IV condition, significant suicide risk, other diseases judged from clinical and laboratory examination Smoking Normal POase
Normal AREase
[34]
Women antidepressant-naive CON: 35
Cases: 35
No PA History of CV and cerebrovascular diseases, DM, hepatic and/or renal diseases, hypothyroidism, malignancies, macroalbuminuria, excessive alcohol consumption, use of hypolipidemic, polyunsaturated fatty acids, vitamins, antioxidants NI Normal AREase [35]
Adults CON: 22
Cases: 24
No PO
PA
Use of alcohol, smoking, GI disease or operation, walking >1 km/ day, health complaints in the previous month, follicular phase NI Normal POase
↓ AREase
[36]
Adults drug-free for 3 months CON: 44
Cases: 73
No PO
PA
Comorbid axis I or II DSM-IV condition, use of alcohol or other substances, diagnosis of a physical disease or syndrome, presence of early CVD in first-degree relatives, pregnancy, BMI>30, regular drug treatment, heavy smokers NI Normal POase
↓ AREase
[37]
Adults CON: 199
Cases: 91
Q192R PO
PA
Comorbid axis I DSM-IV condition, any major medical illness, use of immunoregulatory drugs, acute inflammatory or infective reactions the month prior to the study Sex, age, BMI, education, smoking, PON1 genotype ↓ AREase [38]

Abbreviations: BMI: body mass index; CON: control group; CVD: cardiovascular disease; DM: diabetes mellitus; GI: gastrointestinal; NI: not informed; PA: phenyl acetate; PO: paraoxon.